76345-48-7

Usage

Uses

Used in Chemical Synthesis:
Methanesulfonamide, N-(3,4-diaminophenyl)is used as a ligand in the synthesis of coordination polymers and metal-organic frameworks. Its ability to form hydrogen bonds and coordinate with metal ions makes it a valuable component in creating complex structures with specific properties for various applications.
Used in Pharmaceutical Industry:
Methanesulfonamide, N-(3,4-diaminophenyl)has been studied for its potential use in pharmaceuticals. Its unique chemical properties, including the ability to form hydrogen bonds and coordinate with metal ions, may contribute to the development of new drugs or drug delivery systems.
Used in Food and Beverage Industry:
Methanesulfonamide, N-(3,4-diaminophenyl)is also considered as an additive in food and beverage products. Its potential applications in this industry could include enhancing the stability, taste, or other properties of various products, although it is essential to ensure its safety and proper handling in such applications.

Upstream product

• 1132945-23-3 N-(3,4-dinitrophenyl)methanesulfonamide 
• 5307-14-2 2-nitro-1,4-phenylenediamine 
• 76345-45-4 N-(4-amino-3-nitrophenyl)methanesulphonamide 

Downstream Products

• 337964-73-5 N-[2-(4-phenoxybenzyl)benzimidazol-5-yl]methanesulphonamide 
• 1258290-94-6 N-{2-[4-(4-iodobenzyl)-piperidin-1-ylmethyl]benzimidazol-5-yl}-methanesulfonamide 
• 1430200-29-5 (R)-ethyl 3-(2-amino-4-(methylsulfonamido)phenylamino)-2-(4-fluorobenzyl)-2-hydroxy-3-oxopropanoate 
• 1430200-22-8 C₂₅H₂₉FN₄O₅S 
• 1430200-31-9 (R)-ethyl 3-(4-fluorophenyl)-2-hydroxy-2-(5-(methylsulfonamido)-1H-benzo[d]imidazol-2-yl)propanoate 

Relevant academic research and scientific papers

MINERALOCORTICOID RECEPTOR ANTAGONISTS

The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are aldosterone receptor antagonists which might be useful for treating aldosterone-mediated diseases. The invention furthermore r

Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor

Background and purpose: N-methyl-D-aspartate (NMDA) receptors represent an attractive drug target for the treatment of neurological and neurodegenerative disorders associated with glutamate-induced excitotoxicity. The aim of this study was to map the bind

URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C

Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.

ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Selective Functionalization in 2-Nitro-p-phenylenediamine : Part I - Synthesis of Derivatives of 5-Aminobenzimidazole

2-Nitro-p-phenylenediamine (3) reacts with several electrophilic reagents selectively on the amine meta to the nitro group.The products (4) can be reduced catalytically to the diamines (5) and then cyclized by means of N-carbalkoxy-S-methylpseudothiourea